Recomendaciones de manejo farmacológico en COVID-19
During the month of December last 2019, a series of cases of pneumonia were identified in Wuhan (China), which were caused by a new class of coronavirus. This new class of coronavirus has acquired different names, such as: 2019-nCoV named after the World Health Organization (WHO) and SARS-CoV-2, nam...
Saved in:
Main Authors: | Vargas Parraga, Genesis Carolina, Chafla Pinduisaca, Franklin Fernando, Arelis López Laaz, Susy, Correa Quinto, Wilson Pascual |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
2020
|
Subjects: | |
Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=7591559 |
Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 4, Nº. 2, 2020, pags. 31-39 |
Tags: |
Add Tag
No Tags: Be the first to tag this record
|
Similar Items
-
La Farmacología en tiempos de Covid - 19: Desafíos de su enseñanza y aplicación profesional
by: Ponce Alencastro, Jhon Alexander
Published: (2021) -
La diabetes y las complicaciones con el COVID-19
by: Pinos Robalino, Patricia Judith, et al.
Published: (2020) -
Secuelas que enfrentan los pacientes que superan el COVID 19
by: Lissett Ponce Lino, Leonela, et al.
Published: (2020) -
El Derecho frente a la pandemia por COVID-19
by: Garat, María Paula, et al.
Published: (2020) -
Las medidas de contención de la COVID-19 frente al derecho a la protección de datos personales sanitarios de la CDFUE
by: Sevilla Duro, Miguel Ángel
Published: (2021)